newsfilter
← Latest News
GlobeNewswire·

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting

SAN FRANCISCO, CALIFORNIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the "Company") (NASDAQ:GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on